INCY logo

INCY
Incyte Corp.

5,594
Mkt Cap
$19.09B
Volume
1.16M
52W High
$112.29
52W Low
$53.56
PE Ratio
14.98
INCY Fundamentals
Price
$95.93
Prev Close
$94.30
Open
$93.02
50D MA
$98.19
Beta
0.59
Avg. Volume
1.68M
EPS (Annual)
$6.41
P/B
3.68
Rev/Employee
$1.81M
$16,297.46
Loading...
Loading...
News
all
press releases
J. Safra Sarasin Holding AG Decreases Stake in Incyte Corporation $INCY
J. Safra Sarasin Holding AG lowered its stake in Incyte Corporation (NASDAQ:INCY - Free Report) by 80.9% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 8,406 shares of the biopharmaceutical company's stock after selling 35,655 shares during the quarter. J...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Incyte Reports Strong 54-Week Data From Late-Stage Skin Disorder Study
Incyte's povorcitinib shows sustained 54-week efficacy in HS, with strong response rates and safety profile, reinforcing its potential.
Zacks·4d ago
News Placeholder
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting
Incyte (Nasdaq:INCY) today announced 54-week data evaluating the safety and efficacy of povorcitinib (INCB54707), an oral small-molecule highly-selective JAK1 inhibitor, from the pivotal Phase 3...
Business Wire·6d ago
News Placeholder
Incyte Corporation $INCY Shares Purchased by SG Americas Securities LLC
SG Americas Securities LLC raised its holdings in Incyte Corporation (NASDAQ:INCY - Free Report) by 627.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 186,790 shares of the biopharmaceutical company's stock after buying an additional 16...
MarketBeat·6d ago
News Placeholder
Fairvoy Private Wealth LLC Acquires 24,865 Shares of Incyte Corporation $INCY
Fairvoy Private Wealth LLC lifted its holdings in shares of Incyte Corporation (NASDAQ:INCY - Free Report) by 468.8% during the 4th quarter, according to its most recent Form 13F filing with the...
MarketBeat·6d ago
News Placeholder
Wealth Enhancement Advisory Services LLC Buys 20,988 Shares of Incyte Corporation $INCY
Wealth Enhancement Advisory Services LLC raised its stake in Incyte Corporation (NASDAQ:INCY - Free Report) by 19.7% during the fourth quarter, according to its most recent filing with the Securities...
MarketBeat·7d ago
News Placeholder
UBS Group Lowers Incyte (NASDAQ:INCY) Price Target to $94.00
UBS Group reduced their price target on Incyte from $104.00 to $94.00 and set a "neutral" rating for the company in a report on Wednesday...
MarketBeat·9d ago
News Placeholder
KPTI Stock Down on Mixed Phase III Myelofibrosis Combo Study Data
Karyopharm Therapeutics stock sinks 18% after mixed phase III data show spleen benefit but no symptom edge for selinexor combo in myelofibrosis, raising questions on efficacy.
Zacks·9d ago
News Placeholder
Incyte Announces Executive Leadership Appointments
Incyte (NASDAQ:INCY) today announced appointments among its executive leadership team to support the Companys strategic focus and long-term growth plans. Pablo J. Cagnoni, M.D., has been appointed President, Incyte and Global Head of Research and Development. In this role, Dr. Cagnoni will retain...
Business Wire·9d ago
News Placeholder
Incyte (NASDAQ:INCY) Earns Buy Rating from HC Wainwright
HC Wainwright reissued a "buy" rating and set a $135.00 target price on shares of Incyte in a research report on Wednesday...
MarketBeat·9d ago
<
1
2
...
>

Latest INCY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.